Teva Says Dr. Reddy's Broke Deal Over Birth Control Device
Teva Pharmaceuticals says it is owed more than $31 million after Dr. Reddy's refused to pay for batches of a generic version of birth control device NuvaRing and then declined to...To view the full article, register now.
Already a subscriber? Click here to view full article